Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in patients with extremely large aortic annuli in real-world scenario: First global, multicenter experience.
Andreas HolzamerFrancesco BedogniPieter van WykParag BarwardMarcin ProtasiewiczAlfonso IelasiLuis Nombela-FrancoTim SeidlerMichael HilkerPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
The Myval 32 mm prosthesis showed promising initial results in a cohort of patients who previously had to be excluded from TAVR. It is desirable that all future TAVR systems accommodate larger anatomy to allow optimal treatment of all patients.
Keyphrases
- aortic stenosis
- ejection fraction
- aortic valve
- transcatheter aortic valve replacement
- aortic valve replacement
- transcatheter aortic valve implantation
- left ventricular
- end stage renal disease
- heart failure
- coronary artery disease
- newly diagnosed
- chronic kidney disease
- clinical trial
- prognostic factors
- peritoneal dialysis
- atrial fibrillation
- cross sectional
- coronary artery
- pulmonary artery
- current status